A practical reference on albumin conjugate: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-05-25. Anything still debated is marked as such rather than presented as settled.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Chain length | 29 amino acids | Based on the GRF(1-29) fragment |
| Appearance | White to off-white lyophilized powder | Common research supply form |
| Solubility | Soluble in water and aqueous buffers | Powder requires reconstitution before use |
| Typical storage | −20 °C or below | Kept away from light and moisture |
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.
Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.
The median lethal dose (LD50) for 30 days in dogs after intravenous injection of plutonium is 0.32 milligram per kg of body mass, and thus the lethal dose for humans is approximately 22 mg for a person weighing 70 kg; the amount for respiratory exposure should be approximately four times greater. Another estimate assumes that plutonium is 50 times less toxic than radium, and thus permissible content of plutonium in the body should be 5 μg or 0.3 μCi. Such amount is nearly invisible under microscope. After trials on animals, this maximum permissible dose was reduced to 0.65 μg or 0.04 μCi. Studies on animals also revealed that the most dangerous plutonium exposure route is through inhalation, after which 5–25% of inhaled substances is retained in the body. Depending on the particle size and solubility of the plutonium compounds, plutonium is localized either in the lungs or in the lymphatic system, or is absorbed in the blood and then transported to the liver and bones. Contamination via food is the least likely way. In this case, only about 0.05% of soluble and 0.01% of insoluble compounds of plutonium absorbs into blood, and the rest is excreted. Exposure of damaged skin to plutonium would retain nearly 100% of it. Using actinides in nuclear fuel, sealed radioactive sources or advanced materials such as self-glowing crystals has many potential benefits. However, a serious concern is the extremely high radiotoxicity of actinides and their migration in the environment.
=== A10AE Insulins and analogues for injection, long-acting === A10AE01 Insulin (human) A10AE02 Insulin (beef) A10AE03 Insulin (pork) A10AE04 Insulin glargine A10AE05 Insulin detemir A10AE06 Insulin degludec A10AE07 Insulin icodec A10AE30 Combinations A10AE54 Insulin glargine and lixisenatide A10AE56 Insulin degludec and liraglutide A10AE57 Insulin icodec and semaglutide
In December 2008, Dmitry Medvedev said that Russian defense minister Anatoly Serdyukov informed him around 01:00 on 8 August 2008 that Georgia had declared war on South Ossetia. He declared that Russia was preparing for the war with Georgia. He said that in August 2008, "I did not hesitate even for a second and gave order" to begin military action against Georgia. The Georgian foreign ministry said that Medvedev's statement was a "plea of guilty". In August 2011, Dmitry Medvedev said: "The moment of truth for me, as I realized later while analyzing those events in hindsight over and over again, came with the visit by Secretary of State Condoleezza Rice." He accused Saakashvili of dropping all contacts with the Russian governments following Rice's visit because he was preparing to start the war. Medvedev also said that he talked to Prime Minister Vladimir Putin only the following day after he had made a decision to attack Georgia on his own.
Sources: en.wikipedia.org
In October 2023, Lineage acquired the warehousing and e-commerce assets of Burris Logistics. This deal included eight facilities across six states, adding nearly 1.3 million square feet to Lineage's network.
=== Freeze-dried and frozen fish diets === Freeze-dried and frozen fish foods were primarily developed for tropical and marine fish and are useful in providing variety to the diet or specialist feeding needs of some species. These include tubifex worms, mosquito larvae, bloodworms, water fleas (Daphnia and Cyclops spp.) along with brine shrimp (Artemia salina).
=== Literature === The medal for the Nobel Prize in Literature is given by the Swedish Academy. The reverse of the medal depicts a ' ... young man sitting under a laurel tree who, enchanted, listens to and writes down the song of the Muse'. The 1923 recipient of the literature medal, W. B. Yeats wrote in his 1925 book The Bounty of Sweden that the medal was " ... charming, decorative, academic design, French in manner, a work of the nineties. It shows a young man listening to a Muse, who stands young and beautiful with a great lyre in her hand, and I think as I examine it, 'I was good-looking once like that young man, but my unpractised verse was full of infirmity, my Muse old as it were; and now I am old and rheumatic, and nothing to look at, but my Muse is young". It is inscribed "Inventas vitam iuvat excoluisse per artes" ("It is beneficial to have improved (human) life through discovered arts") an adaptation of "inventas aut qui vitam excoluere per artes" from line 663 from book 6 of the Aeneid by the Roman poet Virgil. A plate below the figures is inscribed with the name of the recipient. The text "ACAD. SUEC." denoting the Swedish Academy is also inscribed on the reverse. It was designed by Erik Lindberg and is manufactured by Svenska Medalj in Eskilstuna.
==== Industrial peeling ==== Efficient techniques have been developed by the industry to peel large quantities of tubers while limiting losses and waste that must then be recycled, usually in animal feed. These techniques are abrasive peeling (the one that produces the most losses), soda peeling (chemical peeling by soaking in a bath of sodium hydroxide at high temperature, followed by rinsing), or steam peeling (a high-pressure steam bath removes the skin from the tubers, which is then vacuumed). The latter method minimizes vitamin losses.
Sources: en.wikipedia.org
== Return, illness, and death == In 1999, the Panamanian government had sought the extradition of Noriega from the U.S., as he had been tried in absentia and found guilty of murder in Panama in 1995. After Noriega was imprisoned in France, Panama asked the French government to extradite Noriega so he could face trial for human rights violations in Panama. The French government had previously stated that extradition would not happen before the case in France had run its course. On September 23, 2011, a French court ordered a conditional release for Noriega to be extradited to Panama on October 1, 2011. Noriega was extradited to Panama on December 11, 2011, and incarcerated at El Renacer prison to serve the sentences, totalling 60 years, that he had accumulated in absentia for crimes committed during his rule. On February 5, 2012, Noriega was moved to Hospital Santo Tomás in Panama City because of high blood pressure and a brain hemorrhage. He remained in the hospital for four days before being returned to prison. It was announced on March 21, 2012, that Noriega had been diagnosed with a brain tumor, which was later revealed to have been benign. On January 23, 2017, he was released from prison and placed under house arrest to prepare for surgery that would remove the tumor. On March 7, 2017, he suffered a brain hemorrhage during surgery which left him in critical condition in the intensive care unit of Hospital Santo Tomás. Noriega died on May 29, 2017, at the age of 83.
=== Creationism === Crick was a firm critic of young Earth creationism. In the 1987 United States Supreme Court case Edwards v. Aguillard, Crick joined a group of other Nobel laureates who advised, "'Creation-science' simply has no place in the public-school science classroom." Crick was also an advocate for the establishment of Darwin Day as a British national holiday.
His plan fails and he rejoins Freeman's group. Freeman then finds Bubby stuck in his old test tube, who had also been betrayed by the military, along with Benry. Freeman reluctantly allows them to rejoin the group. The science team proceed to Black Mesa's Mixology Department, headed by Darnold (Logmore), who gives Freeman a potion that causes his missing arm to regrow into a machine gun. The team fight their way to the Lambda Complex, where they teleport to Xen. In Xen, they find Benry has grown into a giant and begins floating around the others, taunting them. Benry is revealed to be the source of the resonance cascade, transforming into a monstrous alien form and attacking the rest of the science team, who work together to eventually defeat him, by time traveling to the beginning of the game to retrieve their passports. After defeating Benry, Freeman is captured by the G-Man (Spaghoner), who thanks him for taking down Benry and invites him to the birthday party of Tommy, revealed to be the G-Man's adopted son. In the credits sequence, the science team and the G-Man celebrate Tommy's birthday at a Chuck E. Cheese, much to Freeman's despair. In a post-credits scene, Dr. Coomer calls Freeman and congratulates him for beating the game, thanking him for taking the science team with him on his adventure.
The duration of estradiol esters in oil solution by intramuscular injection is dose-dependent. With estradiol valerate, it is reported that a dose of 5 mg has a duration of 7 to 8 days, 10 mg a duration of 10 to 14 days, 40 mg a duration of 2 to 3 weeks, and 100 mg a duration of 3 to 4 weeks. High doses of estradiol valerate, such as 40 mg per week, can achieve pregnancy levels of estradiol. A study of pseudopregnancy with intramuscular injections of 40 mg/week estradiol valerate and 250 mg/week hydroxyprogesterone caproate observed estradiol levels of about 2,500 to 3,000 pg/mL.
Lemurs and humans are both primates. Ancestral primates had brown eyes, as most primates do today. The genetic basis of blue eyes in humans has been studied in detail and much is known about it. It is not the case that one gene locus is responsible, say with brown dominant to blue eye colour. However, a single locus is responsible for about 80% of the variation. In lemurs, the differences between blue and brown eyes are not completely known, but the same gene locus is not involved.
Sources: en.wikipedia.org
No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.
DAC stands for drug affinity complex, a chemical group that binds the peptide to serum albumin. The binding slows clearance and lengthens the time the molecule stays in plasma compared with the unmodified analog.
Because two distinct molecules are discussed under one informal label. The albumin-binding version clears over several days, while the form without that group clears within roughly half an hour. Mixing results from both creates inconsistent figures.
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.